CVA Family Office’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
CVA Family Office's ACLS Position: Q2 2026 in Review
CVA Family Office increased its Axcelis (ACLS) stake by 26% in Q2 2026, buying an estimated $742 and bringing the position to 24 shares worth $4.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.
CVA Family Office first reported a position in ACLS in Q1 2025 and has held it in 3 quarters since. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- CVA Family Office held 24 shares of Axcelis worth $4.55K as of Q2 2026.
- CVA Family Office bought 5 Axcelis shares in Q2 2026, an estimated $742.
- Axcelis made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1300 holding.
- CVA Family Office first reported a position in Axcelis in Q1 2025 and has held it in 3 quarters since.
- 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.